U.S. Markets closed

Alexion’s Soliris Continues to See Growth

Kenneth Smith
Alexion’s Soliris Continues to See Growth

Alexion Pharmaceuticals’ (ALXN) products on the market include Soliris, Strensiq, and Kanuma. Alexion’s Soliris, a humanized monoclonal antibody, is targeted for treating inflammation associated with chronic disorders in hematology, nephrology, and neurology.